| Literature DB >> 33552969 |
Delphine Vuattoux1, Sara Colomer-Lahiguera2,3, Pierre-Alain Fernandez1, Marine Jequier Gygax1, Marie-Louise Choucair4, Maja Beck-Popovic4, Manuel Diezi4, Sabine Manificat1, Sofiya Latifyan5, Anne-Sylvie Ramelet2,6, Manuela Eicher2,3, Nadia Chabane1, Raffaele Renella4.
Abstract
Delivering optimal cancer care to children, adolescents and adults with ASD has recently become a healthcare priority and represents a major challenge for all providers involved. In this review, and after consideration of the available evidence, we concisely deliver key information on this heterogenous group of neurodevelopmental disorders, as well as recommendations and concrete tools for the enhanced oncological care of this vulnerable population of patients.Entities:
Keywords: autism (autism spectrum disorders); cancer; medical oncology; neurodevelopmental disorders; oncology (general); outcome disparities; pediatric oncology; supportive care
Year: 2021 PMID: 33552969 PMCID: PMC7856416 DOI: 10.3389/fonc.2020.595734
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244